A New Way To "Inflation Proof" Your Wealth
When inflation hits an all time high, most investors see gold as a safe haven. However, this unusual investment is seeing 2:1 returns compared to gold. (While still giving you the protection that gold offers)
Click Here To See What It Is

RENX Insider Trading (Renalytix AI)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £441,575

Renalytix AI Insider Trading History Chart

This chart shows the insider buying and selling history at Renalytix AI by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Renalytix AI Share Price & Price History

Current Price: GBX 1,177.50
Price Change: Price Increase of +27.5 (2.39%)
As of 07/29/2021 10:00 PM ET

This chart shows the closing price history over time for RENX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

Renalytix AI Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/22/2021James SterlingInsiderSell12,000GBX 1,500£180,000
6/25/2021Christopher H B MillsInsiderSell6,100GBX 1,125£68,625
6/18/2021Christopher H B MillsInsiderSell17,000GBX 1,135£192,950
12/19/2018Christopher H B MillsInsiderBuy5,970GBX 103£6,149.10
11/6/2018James Renwick McCulloughInsiderBuy16,150GBX 120£19,380
See Full Table
Insider Selling at Renalytix AI?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Renalytix AI and related companies.

SEC Filings (Institutional Ownership Changes) for Renalytix AI (LON:RENX)

Renalytix AI plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record, and systems to generate a unique patient risk score. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. Renalytix AI plc was founded in 2018 and is based in Cardiff, the United Kingdom.
Read More on Renalytix AI

Today's Range

Now: GBX 1,177.50
Low: 1,143
High: 1,190

50 Day Range

MA: GBX 1,096.05
Low: 930
High: 1,210.54

52 Week Range

Now: GBX 1,177.50
Low: 325.20
High: 1,220

Volume

116,890 shs

Average Volume

98,073 shs

Market Capitalization

£850.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Renalytix AI?

Renalytix AI's top insider investors include:
  1. Christopher H B Mills (Insider)
  2. James Sterling (Insider)
A New Way To "Inflation Proof" Your Wealth
When inflation hits an all time high, most investors see gold as a safe haven. However, this unusual investment is seeing 2:1 returns compared to gold. (While still giving you the protection that gold offers)
Click Here To See What It Is